Zobrazeno 1 - 10
of 10
pro vyhledávání: '"D. J. Vidyadhara"'
Autor:
S. N. Suresh, Aravinda K. Chavalmane, Malini Pillai, Veena Ammanathan, D. J. Vidyadhara, Haorei Yarreiphang, Shashank Rai, Abhik Paul, James P. Clement, Phalguni A. Alladi, Ravi Manjithaya
Publikováno v:
Frontiers in Molecular Neuroscience, Vol 11 (2018)
Mechanistic insights into aggrephagy, a selective basal autophagy process to clear misfolded protein aggregates, are lacking. Here, we report and describe the role of Estrogen Related Receptor α (ERRα, HUGO Gene Nomenclature ESRRA), new molecular p
Externí odkaz:
https://doaj.org/article/7773f462a4df4bb7a7da10d3bab13297
Autor:
Eduardo Martin-Lopez, D. J. Vidyadhara, Teresa Liberia, Sarah J. Meller, Leah E. Harmon, Ryan M. Hsu, Natalie Spence, Bowen Brennan, Kimberly Han, Betül Yücel, Sreeganga S. Chandra, Charles A. Greer
Publikováno v:
The Journal of Neuroscience. 43:1051-1071
Parkinson's disease (PD) is characterized by multiple symptoms including olfactory dysfunction, whose underlying mechanisms remain unclear. Here, we explored pathologic changes in the olfactory pathway of transgenic (Tg) mice of both sexes expressing
Autor:
Michael J. Cunningham, Hailey A. Bock, Inis C. Serrano, Benjamin Bechand, D. J. Vidyadhara, Emma M. Bonniwell, David Lankri, Priscilla Duggan, Antonina L. Nazarova, Andrew B. Cao, Maggie M. Calkins, Prashant Khirsariya, Christopher Hwu, Vsevolod Katritch, Sreeganga S. Chandra, John D. McCorvy, Dalibor Sames
Publikováno v:
ACS Chemical Neuroscience. 14:119-135
Autor:
Haorei Yarreiphang, D J Vidyadhara, Anand Krishnan Nambisan, Trichur R Raju, BK Chandrashekar Sagar, Phalguni Anand Alladi
Identification of genetic mutations in Parkinson’s disease (PD) promulgates the genetic nature of disease susceptibility. Resilience-associated genes being unknown till date, the normal genetic makeup of an individual may be determinative too. Our
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49a391cf9d0e29ae860554a054865069
https://doi.org/10.1101/2022.10.05.511004
https://doi.org/10.1101/2022.10.05.511004
Publikováno v:
Journal of visualized experiments : JoVE. (187)
Synaptic terminals are the primary sites of neuronal communication. Synaptic dysfunction is a hallmark of many neuropsychiatric and neurological disorders. The characterization of synaptic sub-compartments by biochemical isolation is, therefore, a po
Autor:
D J Vidyadhara, Mahalakshmi Somayaji, Nigel Wade, Betül Yücel, Helen Zhao, N Shashaank, Joseph Ribaudo, Jyoti Gupta, TuKiet T. Lam, Dalibor Sames, Lois E. Greene, David L. Sulzer, Sreeganga S. Chandra
SUMMARYAuxilin participates in the uncoating of clathrin-coated vesicles (CCVs), thereby facilitating synaptic vesicle (SV) regeneration at presynaptic sites. Auxilin (DNAJC6/PARK19) loss-of- function mutations cause early-onset Parkinson’s disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58eb2bd0f9273f507c775cc96dc58f3b
https://doi.org/10.1101/2022.02.04.479203
https://doi.org/10.1101/2022.02.04.479203
Publikováno v:
Neurotoxicity research. 39(6)
Parkinson disease (PD) prevalence varies by ethnicity. In an earlier study, we replicated the reduced vulnerability to PD in an admixed population, using 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-susceptible C57BL/6 J, MPTP-resistant CD-1 a
Parkinson’s disease (PD) prevalence varies by ethnicity. In an earlier study we replicated the reduced vulnerability to PD in an admixed population, using 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-susceptible C57BL/6J, MPTP-resistant CD-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75228ba8fdad8a0f3522f4499e3c1256
https://doi.org/10.21203/rs.3.rs-452355/v1
https://doi.org/10.21203/rs.3.rs-452355/v1
Autor:
K. G. Mohandas Rao, D. J. Vidyadhara, Kiranmai S. Rai, G. Sivakumar, M. G. Ramesh Babu, T. Rajesh, Shivakumar Reddy
Publikováno v:
International Journal of Basic and Clinical Pharmacology. :522-530
Background: Stroke is the second cause of mortality in the world and third leading cause of disability in surviving victims. Cerebral ischemic cascade involves multiple pathways that can result in motor and cognitive deficits. The current treatment s